New Study Demonstrates Adding 'Singulair' To Children's Usual Asthma Treatment Halves The Number Of Days They Experience Worsened Astma Symptoms

The short term addition of 'Singulair'® (montelukast) to usual asthma therapy
for six weeks after school return could substantially reduce asthma morbidity and
unscheduled physician visits during this predictably high-risk period1. The new study
published in the journal Pediatrics found that asthmatic children in Canada aged 2 to 14,
randomly assigned montelukast in addition to their regular therapy*, experienced half the
number of days with worsened asthma symptoms than those taking placebo (3.9% vs 8.3%;
p

We Recommend:


•   Order Combivir Online
•   Order Anti-Bacterial Face Mask Online
•   Buy Combivir No Prescription
•   Buy Anti-Bacterial Face Mask
•   Order Valtrex